Project Grant RF1NS130069
Award Date
9/19/22
Completion Date
8/31/25
Dollars Obligated
$5M
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research initiative led by Yale University to identify early biomarkers for Alzheimer's disease using advanced neuroimaging techniques. The $460,548 award will fund a longitudinal study that utilizes multi-modal MRI and MRS imaging, along with behavioral testing, to characterize the functional connectivity and mitochondrial energy metabolism changes in the olfactory and memory circuits of an...
This $4.49 million project grant from the National Institutes of Health's National Institute on Aging will fund research at The Washington University to investigate the relationship between amyloid plaque deposition, cellular metabolic dysfunction, and functional brain organization in Alzheimer's disease (AD) mice models. Over three years, the researchers will use multi-photon fluorescence lifetime imaging microscopy, multi-parametric photoacoustic microscopy, and wide-field optical imaging to...
This $837,500 Project Grant awarded by the National Institute on Aging under the Aging Research Federal Grant Program (CFDA 93.866) will fund a research project at Yale University to characterize and validate the use of the PET radiotracer [18F]3F4AP for detecting and quantifying demyelination and cerebral perfusion in Alzheimer's disease, mild cognitive impairment, and cognitively normal individuals. The project aims to perform the first full pharmacokinetic evaluation of this radiotracer in...
This $461,146 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project at Yale University to investigate the disruption of astrocytes, a key cell type in the brain, across different stages of Alzheimer's disease pathology. The project aims to utilize advanced imaging techniques to longitudinally track changes in astrocytic signaling and its coupling with neuromodulatory systems, such as noradrenergic signaling, in two genetic models of...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) will fund a $2,332,368 longitudinal study to elucidate the role of neuronal dysfunction and hyperexcitability in the early biological progression of Alzheimer's disease. The 5-year study, awarded to the University of California, San Francisco, aims to identify the earliest manifestations of neural circuit hyperexcitability that predict accumulation of tau pathology and...
The National Institutes of Health's National Institute on Aging awarded a $4.7 million Project Grant to the University of California, Davis under the Aging Research program (CFDA 93.866) to investigate neuropathogenesis in the interoceptive-allostatic network as part of an animal model of early Alzheimer's disease pathogenesis. The grant will fund detailed neuroimaging and histological analyses of the brain network responsible for generating and regulating affect in rhesus monkeys administered...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop and optimize non-invasive imaging biomarkers to track neuroinflammation in the early stages of Alzheimer's disease (AD). The $812,030 award, effective from December 2024 to November 2029, supports research focused on three key objectives: Investigating the relationship between astrocytic acetate metabolism and astrocyte reactivity in an AD model using deuterium-based magnetic resonance...
This Project Grant award, identified as R01AG081192, was provided by the National Institute on Aging under the Aging Research program (CFDA 93.866) to Baylor College of Medicine in Houston, Texas. The $2,269,085 award, with a project period of June 15, 2024 to March 31, 2029, will fund research to elucidate the basis of hyper- and hypo-connectivity observed in mouse models of Alzheimer's disease (AD). The research will combine high-resolution in vivo MRI imaging with state-of-the-art spatial...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a multimodal neuroimaging study to investigate sex-based differences in brain circuitry and their relationship to Alzheimer's disease pathology. The $815,215 project, which runs from May 2025 to February 2030, will leverage a new prospective cohort and open-source datasets to assess the impact of sex and sex-based factors, such as reproductive period and APOE genotype, on functional brain...
This $1,758,779 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research to assess the neuronal vulnerability of excitatory and inhibitory neurons in the entorhinal cortex due to Alzheimer's disease pathology. The research aims to determine whether hyperexcitability in this brain region is caused by dysfunction of excitatory or inhibitory neurons. Using mouse models of Alzheimer's disease, the project will employ optogenetic, chemogenetic, and...